Linked Life Data

3937535

Source:http://linkedlifedata.com/resource/pubmed/id/3937535

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3937535rdf:typepubmed:Citationlld:pubmed
pubmed-article:3937535lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3937535lifeskim:mentionsumls-concept:C0241888lld:lifeskim
pubmed-article:3937535lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:3937535lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:3937535lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:3937535lifeskim:mentionsumls-concept:C0342883lld:lifeskim
pubmed-article:3937535lifeskim:mentionsumls-concept:C1705822lld:lifeskim
pubmed-article:3937535lifeskim:mentionsumls-concept:C0348011lld:lifeskim
pubmed-article:3937535pubmed:issue1-3lld:pubmed
pubmed-article:3937535pubmed:dateCreated1986-3-5lld:pubmed
pubmed-article:3937535pubmed:abstractTextLipoprotein patterns and cholesteryl ester transfer activity (CETA) were examined in 2 patients with familial hyperalphalipoproteinaemia (FHALP). The proband was a healthy 58-year-old Japanese male who had an HDL cholesterol of 7.83 mmol/l (301 mg/dl). His sister's HDL cholesterol was 4.52 mmol/l (174 mg/dl), which suggested that both were homozygous carriers of FHALP. In both subjects HDL showed a high cholesterol/apo A-I ratio and appeared to be a larger-sized particle than normal HDL on agarose gel chromatography. Two of the proband's children showed higher HDL cholesterol levels (1.74 mmol/l, 2.16 mmol/l) than normal, but another 2 children showed normal levels (1.48 mmol/l, 1.40 mmol/l). However, the ratios of HDL cholesterol to total cholesterol and to apo A-I in all children were higher than normal. These data suggest, but do not prove, that all his children were heterozygotes. Apo B levels in all of the family members studied were lower than normal (47-80 mg/dl). Deceased members of the same family had not died from cardiovascular disease. Cholesteryl-ester transfer activity was studied in both patients. When serum or lipoprotein deficient serum (d greater than 1.21) and [3H]cholesteryl ester labelled HDL3 were incubated in the presence of an LCAT inhibitor, there was no evidence of cholesteryl ester transfer from HDL to VLDL and/or LDL, unlike normal subjects. The deficiency of CETA in these patients with FHALP presumably accounted for the increase in particle size and cholesterol enrichment of HDL.lld:pubmed
pubmed-article:3937535pubmed:languageenglld:pubmed
pubmed-article:3937535pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:citationSubsetIMlld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3937535pubmed:statusMEDLINElld:pubmed
pubmed-article:3937535pubmed:monthDeclld:pubmed
pubmed-article:3937535pubmed:issn0021-9150lld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:ItohHHlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:SakaiTTlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:TakedaRRlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:TakedaMMlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:SakaiYYlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:UedaKKlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:MabuchiHHlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:KoizumiJJlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:YoshimuraAAlld:pubmed
pubmed-article:3937535pubmed:authorpubmed-author:MichishitaIIlld:pubmed
pubmed-article:3937535pubmed:issnTypePrintlld:pubmed
pubmed-article:3937535pubmed:volume58lld:pubmed
pubmed-article:3937535pubmed:ownerNLMlld:pubmed
pubmed-article:3937535pubmed:authorsCompleteYlld:pubmed
pubmed-article:3937535pubmed:pagination175-86lld:pubmed
pubmed-article:3937535pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:meshHeadingpubmed-meshheading:3937535-...lld:pubmed
pubmed-article:3937535pubmed:year1985lld:pubmed
pubmed-article:3937535pubmed:articleTitleDeficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia.lld:pubmed
pubmed-article:3937535pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3937535pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3937535lld:pubmed